Calumet (CLMT) Projected to Post Earnings on Friday

Calumet (NASDAQ:CLMT) will likely be releasing its Q3 2025 results before the market opens on Friday, November 7th. Analysts expect the company to announce earnings of ($0.35) per share and revenue of $1.0614 billion for the quarter. Individuals may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Friday, November 7, 2025 at 9:00 AM ET.

Calumet (NASDAQ:CLMT) last issued its quarterly earnings data on Friday, August 8th. The oil and gas company reported ($1.70) earnings per share for the quarter, missing the consensus estimate of ($0.44) by ($1.26). The business had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $982.88 million. During the same quarter last year, the company earned ($0.48) earnings per share. The company’s revenue was down 9.4% on a year-over-year basis. On average, analysts expect Calumet to post $-3 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Calumet Trading Down 1.8%

NASDAQ:CLMT opened at $19.73 on Wednesday. The stock has a market capitalization of $1.71 billion, a P/E ratio of -3.78 and a beta of 0.98. Calumet has a 1 year low of $7.68 and a 1 year high of $23.75. The firm has a 50 day moving average of $18.37 and a 200-day moving average of $15.82.

Analyst Ratings Changes

CLMT has been the topic of a number of recent analyst reports. The Goldman Sachs Group boosted their price objective on Calumet from $15.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday, October 22nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Calumet in a report on Wednesday, October 8th. UBS Group increased their price objective on shares of Calumet from $12.00 to $13.25 and gave the stock a “neutral” rating in a report on Tuesday, August 12th. Finally, Zacks Research cut shares of Calumet from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 7th. Four analysts have rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $19.71.

Hedge Funds Weigh In On Calumet

Large investors have recently bought and sold shares of the business. Engineers Gate Manager LP acquired a new position in shares of Calumet in the 2nd quarter valued at $230,000. Quantbot Technologies LP acquired a new position in shares of Calumet during the 2nd quarter worth about $241,000. New York State Common Retirement Fund acquired a new stake in shares of Calumet in the 2nd quarter valued at approximately $343,000. The Manufacturers Life Insurance Company boosted its stake in Calumet by 199.9% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 34,551 shares of the oil and gas company’s stock worth $544,000 after acquiring an additional 23,031 shares during the last quarter. Finally, Corient Private Wealth LLC acquired a new position in Calumet during the second quarter valued at approximately $577,000. 34.41% of the stock is currently owned by institutional investors and hedge funds.

Calumet Company Profile

Calumet, Inc engages in the manufacturing, formulating, and marketing of a diversified slate of specialty branded products and renewable fuels to customers across a broad range of consumer-facing and industrial markets. It operates through the following segments: Specialty Products & Solutions, Performance Brands, Montana/Renewables, and Corporate.